SCHEMBL15575337

SCHEMBL15575337

[CH2]c1ccc(-c2ccc(S(=O)(=O)NC)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.57
GAA P10253 1/20 0.57
CA12 O43570 2/20 0.55
CA1 P00915 2/20 0.55
CA2 P00918 2/20 0.55
CA3 P07451 2/20 0.55
CA4 P22748 2/20 0.55
CA6 P23280 2/20 0.55
CA5A P35218 2/20 0.55
CA7 P43166 2/20 0.55
CA9 Q16790 2/20 0.55
CA13 Q8N1Q1 2/20 0.55
CA14 Q9ULX7 2/20 0.55
CA5B Q9Y2D0 2/20 0.55
LMNA P02545 3/20 0.53
HTT P42858 1/20 0.53
ALDH1A1 P00352 3/20 0.52
KIF11 P52732 1/20 0.51
NR3C2 P08235 1/20 0.46
TAS2R14 Q9NYV8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1751946 0.94 SMN1; SMN2 (0.64) SMN1; SMN2GAACA12CA1CA2
SCHEMBL8080277 0.89 SMN1; SMN2 (0.70) SMN1; SMN2GAACA12CA1CA2
SCHEMBL7629070 0.82 SMN1; SMN2 (0.80) SMN1; SMN2GAACA12CA1CA2
SCHEMBL3906959 0.81 NR3C2 (0.61) SMN1; SMN2GAACA12CA1CA2
SCHEMBL6609278 0.79 SMN1; SMN2 (0.57) SMN1; SMN2GAACA12CA1CA2
SCHEMBL6609080 0.78 SMN1; SMN2 (0.55) SMN1; SMN2GAACA12CA1CA2
SCHEMBL22017102 0.77 SMN1; SMN2 (0.55) SMN1; SMN2GAACA12CA1CA2
SCHEMBL6295429 0.76 PTGS2 (0.52) KIF11PTGS2
SCHEMBL3642921 0.75 CA12 (0.59) SMN1; SMN2GAACA12CA1CA2
SCHEMBL30960 0.73 GAA (1.00) SMN1; SMN2GAACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014035872-A1 TRICYCLIC ALKYNES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN AMGEN INC. (US) 2014-03-06 WO disclosed